• No results found

[PDF] Top 20 Moderated Poster Session 2: Functional Urology

Has 10000 "Moderated Poster Session 2: Functional Urology" found on our website. Below are the top 20 most common "Moderated Poster Session 2: Functional Urology".

Moderated Poster Session 2: Functional Urology

Moderated Poster Session 2: Functional Urology

... to urology 6 patients (19%) had prior failed repairs: 4 patients with 1, 1 patient with 2, and 1 patient with 4 prior ...from 2 weeks to 30 ... See full document

5

Moderated Poster Session 6: Oncology

Moderated Poster Session 6: Oncology

... Introduction and Objective: Several studies have examined the rela- tionship between insulin-like growth factor I (IGF-I), and its binding pro- teins 2 (IGFBP-2) and 3 (IGFBP-3) with prostate cancer risk. A ... See full document

6

Moderated Poster Session II: Reconstruction/Andrology

Moderated Poster Session II: Reconstruction/Andrology

... removal. Urology was also consulted to evaluate need for urologic procedures, assess extent of genital involvement and manage artificial urinary ...by urology for burn injury ... See full document

7

Moderated Poster Session 8: Miscellaneous

Moderated Poster Session 8: Miscellaneous

... Materials and Methods: Sixty-nine (of a preplanned sample size of 74) patients scheduled to undergo LapDN were enrolled and randomized. All patients underwent a transperitoneal, 3 trocar, LapDN performed by 2 sur- ... See full document

5

Moderated Poster Session III: Oncology 1

Moderated Poster Session III: Oncology 1

... of functional status: activities of daily living (ADL) deficiency (categorized as no ADL deficiency or any ADL deficiency), proxy survey response, and the Medical Outcomes Study Short Form 36 (SF-36) and ... See full document

7

Moderated Poster Session VI: Education

Moderated Poster Session VI: Education

... Background: Many institutions have optimized simulation-based train- ing by incorporating deliberate practice (DP) protocols. We previously demonstrated that, medical student, simulation-based deliberate practice ... See full document

7

Moderated Poster Session I: Oncology

Moderated Poster Session I: Oncology

... Results: Prostate adenocarcinoma was detected in 23/50 ASAP and 26/50 first-time biopsy patients with eight and 17, respectively, having signifi- cant disease. ASAP patients had greater benefit from MRI-TRUS fusion ... See full document

6

Moderated Poster Session 2: Basic Research

Moderated Poster Session 2: Basic Research

... Materials and Methods: Patients were stratified according to suspected depth of tumor invasion (< T1, > T2). The primary endpoint was reduc- tion in activation of the epidermal growth factor receptor (EGF-R) as ... See full document

7

Moderated Poster Session 1: Oncology I

Moderated Poster Session 1: Oncology I

... Methods: Patients scheduled to undergo partial or radical nephrectomy with suspicion for renal cell cancer were consented for our study. Immediately following nephrectomy, MPI was performed on excised kid- ney specimens. ... See full document

10

Moderated Poster Session 1: Basic Science

Moderated Poster Session 1: Basic Science

... Methods: Utilizing the subrenal prostatic recapitulation model for tis- sue recombination, rat urogenital mesenchyme (rUGM) was microdis- sected from rat embryos and combined with 10-20 mg slivers of prostate tumor or ... See full document

7

Moderated Poster Session 8: Kidney Cancer

Moderated Poster Session 8: Kidney Cancer

... Introduction and Objective: Sunitinib is an established treatment for metasta- tic renal cell carcinoma (RCC). Neoadjuvant sunitinib may facilitate surgi- cal resection by reducing primary tumor size and may decrease ... See full document

5

Moderated Poster Session 4: Bladder Cancer

Moderated Poster Session 4: Bladder Cancer

... Materials and Methods: We collected and pooled a database of 2,287 patients who have undergone radical cystectomy for carcinoma of the bladder between 1993 and 2008 in 8 different centers across Canada. Complete ... See full document

6

Moderated Poster Session 1: Prostate Cancer

Moderated Poster Session 1: Prostate Cancer

... Materials and Methods: A retrospective analysis of 305 consecutive patients undergoing PB from 1997 to 2003 was performed. Patients with pubic arch interference seen on planning transrectal ultrasound were given a short ... See full document

5

Moderated Poster Session 1: Oncology 1

Moderated Poster Session 1: Oncology 1

... the 2 groups, including; operative time, esti- mated blood loss (EBL), transfusion rate, length of stay (LOS), positive margin rate (PSM), complications (Cxs), decrease in glomerular filtration rates (eGFR), as ... See full document

10

Moderated Poster Session I: Oncology 1

Moderated Poster Session I: Oncology 1

... carcinoma with possible lymphatic invasion. Patient declined radical cys- tectomy and chose combination radiotherapy and chemotherapy. In order to outline a bladder tumour margins, the patient agreed to undergo an ... See full document

6

Moderated Poster Session 3: Oncology II

Moderated Poster Session 3: Oncology II

... Background: We present our 5 year outcomes in men undergoing pros- tate brachytherapy with Cesium 131 (131Cs). Cesium 131 is a relatively newer isotope proposed to have a shorter duration of lower urinary tract symptoms ... See full document

7

Moderated Poster Session 2: Kidney Cancer

Moderated Poster Session 2: Kidney Cancer

... follow up was 7.8 months (2-11). Tumor size averaged 3.2 cm (0.9-6.5). Tumors were peripheral and exophytic in 8 and hilar in 5 patients. Average R.E.N.A.L. nephrometry score was 7.7 (5-11). A total of 13 lesions ... See full document

6

Moderated Poster Session 3: Oncology 2

Moderated Poster Session 3: Oncology 2

... Background: Prostate brachytherapy (PB) has been accepted as an onco- logically effective treatment for clinically localized prostate cancer. A sig- nificant downside associated with PB is the bothersome urinary symptoms ... See full document

7

Moderated Poster Session 6: Pediatric Urology

Moderated Poster Session 6: Pediatric Urology

... Results: Overall, the average cost for a laparoscopic pyeloplasty was Can$6240 compared with Can$5079 for an open procedure with a medi- an hospital stay of 2 days for both groups (range OA: 1–18, LP: 1–7). ... See full document

6

Moderated Poster Session VI: Infertility/Impotence, General Urology

Moderated Poster Session VI: Infertility/Impotence, General Urology

... Background: PROPPER is designed to document outcomes for AMS 700 and AMS Ambicor inflatable penile prostheses (IPPs), and Spectra penile implants. Validated patient questionnaires and electronic data collection are used ... See full document

6

Show all 10000 documents...